Cegedim SA (0DYQ.L)
EUR 11.45
(-2.55%)
EUR 11.45
(-2.55%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 615.99 Million EUR | 10.95% |
| 2022 | 555.2 Million EUR | 5.81% |
| 2021 | 524.7 Million EUR | 5.59% |
| 2020 | 496.93 Million EUR | -1.35% |
| 2019 | 503.74 Million EUR | 7.71% |
| 2018 | 467.68 Million EUR | 2.24% |
| 2017 | 457.44 Million EUR | 3.76% |
| 2016 | 440.84 Million EUR | 3.45% |
| 2015 | 426.15 Million EUR | -13.65% |
| 2014 | 493.49 Million EUR | -45.3% |
| 2013 | 902.25 Million EUR | -2.12% |
| 2012 | 921.77 Million EUR | 1.13% |
| 2011 | 911.46 Million EUR | -1.64% |
| 2010 | 926.67 Million EUR | 6.02% |
| 2009 | 874.07 Million EUR | 3.0% |
| 2008 | 848.57 Million EUR | 12.69% |
| 2007 | 752.99 Million EUR | 39.13% |
| 2006 | 541.2 Million EUR | 492.62% |
| 2005 | 91.32 Million EUR | -78.97% |
| 2004 | 434.35 Million EUR | 11.66% |
| 2003 | 389.01 Million EUR | 14.39% |
| 2002 | 340.07 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 159.49 Million EUR | 1.27% |
| 2024 Q2 | 159.49 Million EUR | 0.0% |
| 2023 FY | 615.99 Million EUR | 10.95% |
| 2023 Q4 | 157.49 Million EUR | 0.0% |
| 2023 Q2 | 150.5 Million EUR | 0.0% |
| 2023 Q1 | 150.5 Million EUR | 4.65% |
| 2023 Q3 | 157.49 Million EUR | 4.64% |
| 2022 Q3 | 143.82 Million EUR | -46.25% |
| 2022 Q1 | 133.78 Million EUR | -51.1% |
| 2022 Q4 | 143.82 Million EUR | 0.0% |
| 2022 Q2 | 267.56 Million EUR | 100.0% |
| 2022 FY | 555.2 Million EUR | 5.81% |
| 2021 FY | 524.7 Million EUR | 5.59% |
| 2021 Q1 | 125.57 Million EUR | -51.84% |
| 2021 Q2 | 251.15 Million EUR | 100.0% |
| 2021 Q4 | 273.55 Million EUR | 100.0% |
| 2021 Q3 | 136.77 Million EUR | -45.54% |
| 2020 Q3 | 130.37 Million EUR | -44.81% |
| 2020 Q2 | 236.19 Million EUR | 100.0% |
| 2020 FY | 496.93 Million EUR | -1.35% |
| 2020 Q1 | 118.09 Million EUR | -54.22% |
| 2020 Q4 | 260.74 Million EUR | 100.0% |
| 2019 Q4 | 257.95 Million EUR | 100.0% |
| 2019 Q2 | 122.89 Million EUR | 0.0% |
| 2019 Q1 | 122.89 Million EUR | 2.39% |
| 2019 FY | 503.74 Million EUR | 7.71% |
| 2019 Q3 | 128.97 Million EUR | 4.95% |
| 2018 FY | 467.68 Million EUR | 2.24% |
| 2018 Q1 | 113.81 Million EUR | -2.46% |
| 2018 Q2 | 113.81 Million EUR | 0.0% |
| 2018 Q3 | 120.02 Million EUR | 5.46% |
| 2018 Q4 | 120.02 Million EUR | 0.0% |
| 2017 Q1 | 112.03 Million EUR | -8.54% |
| 2017 Q4 | 116.68 Million EUR | 0.0% |
| 2017 Q3 | 116.68 Million EUR | 4.15% |
| 2017 FY | 457.44 Million EUR | 3.76% |
| 2017 Q2 | 112.03 Million EUR | 0.0% |
| 2016 Q2 | 109.3 Million EUR | 2.91% |
| 2016 Q1 | 106.2 Million EUR | 78.23% |
| 2016 Q3 | 102.83 Million EUR | -5.91% |
| 2016 Q4 | 122.5 Million EUR | 19.12% |
| 2016 FY | 440.84 Million EUR | 3.45% |
| 2015 Q2 | 124.83 Million EUR | 2.91% |
| 2015 FY | 426.15 Million EUR | -13.65% |
| 2015 Q4 | 59.59 Million EUR | -50.51% |
| 2015 Q3 | 120.41 Million EUR | -3.54% |
| 2015 Q1 | 121.3 Million EUR | 181.33% |
| 2014 FY | 493.49 Million EUR | -45.3% |
| 2014 Q4 | -149.15 Million EUR | -169.72% |
| 2014 Q3 | 213.92 Million EUR | -4.79% |
| 2014 Q2 | 224.67 Million EUR | 10.11% |
| 2014 Q1 | 204.05 Million EUR | -19.67% |
| 2013 Q2 | 224.36 Million EUR | 5.4% |
| 2013 Q3 | 211.01 Million EUR | -5.95% |
| 2013 Q4 | 254.01 Million EUR | 20.38% |
| 2013 FY | 902.25 Million EUR | -2.12% |
| 2013 Q1 | 212.86 Million EUR | -18.42% |
| 2012 Q4 | 260.91 Million EUR | 25.69% |
| 2012 Q1 | 214.2 Million EUR | 0.0% |
| 2012 Q2 | 239.06 Million EUR | 11.61% |
| 2012 Q3 | 207.58 Million EUR | -13.17% |
| 2012 FY | 921.77 Million EUR | 1.13% |
| 2011 FY | 911.46 Million EUR | -1.64% |
| 2010 FY | 926.67 Million EUR | 6.02% |
| 2009 FY | 874.07 Million EUR | 3.0% |
| 2008 FY | 848.57 Million EUR | 12.69% |
| 2007 FY | 752.99 Million EUR | 39.13% |
| 2006 FY | 541.2 Million EUR | 492.62% |
| 2005 FY | 91.32 Million EUR | -78.97% |
| 2004 FY | 434.35 Million EUR | 11.66% |
| 2003 FY | 389.01 Million EUR | 14.39% |
| 2002 FY | 340.07 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Guerbet SA | 795.65 Million EUR | 22.58% |
| Nexus AG | 241.45 Million EUR | -155.114% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | -16.279% |
| Revenio Group Oyj | 96.57 Million EUR | -537.834% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 81.74% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 81.86% |
| LNA Santé SA | 736.08 Million EUR | 16.315% |
| Siemens Healthineers AG | 22.36 Billion EUR | 97.245% |
| Medios AG | 1.78 Billion EUR | 65.485% |
| Equasens Société anonyme | 219.78 Million EUR | -180.268% |
| Stratec SE | 261.91 Million EUR | -135.192% |